Eligo inks deal with GSK potentially worth up to $224M
- Monday, January 11, 2021, 7:12
- Environment
- Add a comment
PARIS, Jan. 11, 2021 /PRNewswire/ — Eligo Bioscience SA (Eligo) today announced that it has entered into a research and option agreement with GlaxoSmithKline (NYSE: GSK) aimed at advancing Eligobiotics® for the treatment or prevention of acne vulgaris with a pioneering CRISPR-based…
About the Author
adminasapcorp has written 41562 stories on this site.